The reorganization of Zeiss' vision care activities goes on. The Carl Zeiss Group has signed an agreement in principle to merge its ophthalmology equipment business unit, including its ophthalmic systems operations in Jena, Germany and Dublin, California, with Asclepion-Meditec, a public German company based also in Jena.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.